Tag: Pharma
Big Pharma give insight into Lyophilisation through 3 exclusive new interviews
London, UK (PRWEB UK) 20 May 2015 Following on from the well-received US show, part 2 of the Global Lyophilisation 2015 series, Lyophilisation Europe, will bring together specialists from around the world to develop possible strategies for future initiatives with a focus on QbD and PAT principles. In the run up to the show, […]
Dalton Pharma Services Expands Sterile Powder Manufacturing Capabilities
Toronto, ON (PRWEB) January 27, 2015 Dalton Pharma Services today announced expanded cGMP sterile powder filling capabilities as part of its ongoing focus on sterile processing and manufacturing. The expansion includes the addition of a high-speed automated sterile powder filling line that will enable Dalton to efficiently fill large commercial batches of vials. The […]
USP Laboratory in India Welcomes Maryland Civic & Business Leaders; Works to Enhance Pharma and Bio-Tech Connections
Rockville, Maryland (PRWEB) November 14, 2014 Staff from the U.S. Pharmacopeial Convention (USP) today welcomed a visiting delegation of community and business leaders from Montgomery County, Maryland to USP’s state-of-the-art laboratories in Hyderabad, India as part of an effort to strengthen connections with pharmaceutical and bio-tech organizations. Visitors to the USP-India facility included Montgomery […]
New regulatory and pricing trends this decade brings a paradigm shift to the pharma industry
London, Southwark (PRWEB UK) 5 August 2014 New regulatory and pricing trends emerging this decade bring a paradigm shift that the industry must respond to and embrace to ensure success. The future will bring increased responsibilities to pharmaceutical manufacturers, but will also open the door for new opportunities. (Source: Alliance Life Sciences Company Blog, […]
Frontier Pharma Rheumatoid Arthritis Identifying and Commercializing First-in-Class Innovation: MarketResearchReports.Biz
Albany, NY (PRWEB) July 30, 2014 Frontier Pharma: Rheumatoid Arthritis Identifying and Commercializing First-in-Class Innovation”. This highly competitive market is saturated with multiple targeted monoclonal Antibody (mAb) therapies and small molecules, yet more of these treatments are expected to enter the market over the next few years. Despite this, the current developmental pipeline is highly […]